TLDR Anthropic filed a lawsuit against the US Department of Defense over a supply chain risk designation. The designation restricts Anthropic from working with TLDR Anthropic filed a lawsuit against the US Department of Defense over a supply chain risk designation. The designation restricts Anthropic from working with

Anthropic Sues US Over Supply Chain Risk Blacklist

2026/03/10 01:24
3 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

TLDR

  • Anthropic filed a lawsuit against the US Department of Defense over a supply chain risk designation.
  • The designation restricts Anthropic from working with defense contractors on federal projects.
  • Federal officials labeled the company after talks failed over surveillance and weapons use.
  • Anthropic refused to allow its systems for mass surveillance of Americans or autonomous weapons.
  • The Pentagon paused a contract valued at up to 200 million dollars following the dispute.

Anthropic has filed a lawsuit against the US Department of Defense and other federal agencies over a supply chain risk designation. The company challenges the Trump administration’s decision that restricts its work with defense contractors. The dispute centers on failed talks about surveillance use and a Pentagon contract valued at up to $200 million.

Anthropic Challenges Federal Supply Chain Risk Designation

Anthropic filed the lawsuit after federal agencies labeled the company a supply chain risk and restricted defense partnerships. The designation followed collapsed talks between the company and defense officials over permitted uses of its systems. Federal officials insisted the technology must support all lawful purposes, including surveillance and weapons programs.

However, Anthropic refused to allow its systems for mass surveillance of Americans or autonomous weapons. As talks ended, the government halted adoption plans and jeopardized a Pentagon deal worth up to $200 million. The company argues the classification lacks legal basis and seeks judicial review to protect its operations.

An Anthropic spokesperson told CNN, “Seeking judicial review does not change our longstanding commitment to harnessing AI to protect our national security.” The spokesperson added that the lawsuit protects its business, customers, and partners. Meanwhile, the Pentagon maintained that lawful use requirements remain essential for defense technology.

Defense Contract Dispute and Corporate Responses

The Financial Times reported that Chief Executive Dario Amodei sought last-minute negotiations with defense leaders. He attempted to de-escalate tensions and prevent a formal blacklist. However, the effort failed to stop the supply chain risk classification.

Following the designation, federal agencies limited cooperation with Anthropic in defense projects. The Pentagon stated that contractors must ensure full lawful access to deployed systems. Officials maintained that defense technology providers must meet comprehensive operational requirements.

Despite the government dispute, Anthropic’s consumer business showed resilience. The company’s Claude application surpassed OpenAI’s ChatGPT in Apple App Store rankings after news of the contract termination. By early March, Anthropic reported that more than one million users signed up for Claude daily.

Major technology companies responded to the federal classification with public statements. Google confirmed it would continue providing Anthropic technology to cloud customers for non-defense purposes. Microsoft issued a similar statement, and Amazon said it would maintain access outside defense work.

Anthropic continues discussions with government officials while pursuing its lawsuit in federal court. The company maintains that the designation lacks a clear statutory foundation. As of early March, more than one million users join Claude daily, according to company data

The post Anthropic Sues US Over Supply Chain Risk Blacklist appeared first on Blockonomi.

Market Opportunity
MASS Logo
MASS Price(MASS)
$0.0006348
$0.0006348$0.0006348
-2.45%
USD
MASS (MASS) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Bio Protocol Raises $6.9M to Advance AI-Powered Decentralized Science

Bio Protocol Raises $6.9M to Advance AI-Powered Decentralized Science

The post Bio Protocol Raises $6.9M to Advance AI-Powered Decentralized Science appeared on BitcoinEthereumNews.com. Decentralized science (DeSci) platform Bio Protocol secured backing from investors including Maelstrom Fund and Animoca Brands to expand its artificial intelligence-native biotech research framework.  Bio Protocol announced Wednesday that it had raised $6.9 million in funding, reflecting growing interest in decentralized approaches to drug discovery that integrate AI, blockchain and community engagement.  Maelstrom founder Arthur Hayes described Bio Protocol as a potential “category-defining launchpad” for scientific research. “If it works, it’s not just a launchpad – it’s the birth of an AI-native research market,” he said. Hayes also highlighted how it opens up research opportunities that communities find appealing, not just what academics find interesting.  Cointelegraph reached out to Maelstrom and Animoca for more information, but did not receive a response by publication.  Source: Bio Protocol Speeding up science using AI and crypto DeSci is a movement that uses blockchain technology, crypto incentives and decentralized governance to change how scientific research is conducted, funded and shared. Bio Protocol said it’s speeding up science by integrating crypto and AI. Its approach compresses the drug discovery pipeline using blockchain-based funding and coordination.  Instead of waiting years for traditional grants to be awarded or pharma partnerships to be formed, researchers can use decentralized AI agents, dubbed “BioAgents” that generate hypotheses, connect to onchain wallets and channel community-raised capital into experiments.  Each step of the process will be recorded onchain, ensuring that contributors will be credited and maintaining an immutable record of research progress.  The protocol also uses crypto-native incentives to keep research moving faster. It uses tokenized intellectual property, staking systems and loyalty rewards to align investors, researchers and community members around shared outcomes.  Related: ‘Science needs an update’: How DeSci can fix junk science and cure baldness Addressing inefficiencies in academic research Simon Dedic, the founder of Moonrock Capital, one of Bio…
Share
BitcoinEthereumNews2025/09/19 11:05
Winklevoss Brothers’ $130M Bitcoin Move Sparks Market Scrutiny and Strategic Speculation

Winklevoss Brothers’ $130M Bitcoin Move Sparks Market Scrutiny and Strategic Speculation

BitcoinWorld Winklevoss Brothers’ $130M Bitcoin Move Sparks Market Scrutiny and Strategic Speculation NEW YORK, April 2025 – A substantial Bitcoin transaction
Share
bitcoinworld2026/03/10 19:10
YouTube Surpasses Disney as World’s Largest Media Giant With $62.3B Revenue

YouTube Surpasses Disney as World’s Largest Media Giant With $62.3B Revenue

YouTube generated $62.3B in 2025 revenue, surpassing Disney to become the world's largest media company, valued at $500B-$560B by MoffettNathanson. The post YouTube
Share
Blockonomi2026/03/10 19:31